The endometriosis global market report 2024 from The Business Research Company provides comprehensive market statistics, including global market size, regional shares, competitor market share, detailed segments, trends, and opportunities. This report offers an in-depth analysis of current and future industry scenarios, delivering a complete perspective for thriving in the industrial automation software market.
Endometriosis Market, 2024 report by The Business Research Company offers comprehensive insights into the current state of the market and highlights future growth opportunities.
Market Size –
The endometriosis market size has grown rapidly in recent years. It will grow from $1.27 billion in 2023 to $1.4 billion in 2024 at a compound annual growth rate (CAGR) of 10.4%. The growth in the historic period can be attributed to delayed diagnosis and increased awareness, advances in laparoscopic surgery, hormonal therapies, patient advocacy and support groups.
The endometriosis market size is expected to see strong growth in the next few years. It will grow to $2.01 billion in 2028 at a compound annual growth rate (CAGR) of 9.3%. The growth in the forecast period can be attributed to minimally invasive procedures, pharmaceutical innovations, genetic and epigenetic research, global expansion of women’s healthcare. Major trends in the forecast period include patient-centered care, precision medicine, virtual care and telemedicine, fertility preservation.
Order your report now for swift delivery @
https://www.thebusinessresearchcompany.com/report/endometriosis-global-market-report
Scope Of Endometriosis Market
The Business Research Company’s reports encompass a wide range of information, including:
1. Market Size (Historic and Forecast): Analysis of the market’s historical performance and projections for future growth.
2. Drivers: Examination of the key factors propelling market growth.
3. Trends: Identification of emerging trends and patterns shaping the market landscape.
4. Key Segments: Breakdown of the market into its primary segments and their respective performance.
5. Focus Regions and Geographies: Insight into the most critical regions and geographical areas influencing the market.
6. Macro Economic Factors: Assessment of broader economic elements impacting the market.
Endometriosis Market Overview
Market Drivers –
The increasing incidence of ovarian cancer is expected to propel the growth of the endometriosis market going forward. Ovarian cancer is a type of cancer that begins in the ovaries, the female reproductive organs responsible for producing eggs and the hormones estrogen and progesterone. Endometriosis is associated with an increased risk of developing epithelial ovarian cancer, mainly the endometrioid and precise cell cancer subtypes, characterized by high estrogen concentrations, which can increase the risk of developing ovarian cancer. For instance, in January 2023, according to the American Cancer Society, a US-based professional organization, it is projected that approximately 19,710 new cases of ovarian cancer will be diagnosed among women in the US in 2023. Furthermore, in 2022, according to the Ovarian Cancer Research Alliance, a US-based not-for-profit organization, ovarian cancer caused 12,810 deaths in 2022 and increased to 13,270 fatalities in 2023. Therefore, the increasing incidence of ovarian cancer is driving the growth of the endometriosis market.
Market Trends –
Major companies operating in the endometriosis market are focused on developing innovative drugs such as Myfembree and getting approvals to provide new patient treatment options. The introduction of novel endometriosis medications addresses a previously unmet demand for effective treatments. For instance, in August 2022, Myovant Sciences GmbH, a Switzerland-based biopharmaceutical company and Pfizer Inc., a US-based pharmaceutical industry company, received approval for Myfembree from the U.S. Food and Drug Administration (FDA) for the management of moderate to severe pain associated with endometriosis in premenopausal women. Myfembree is a once-daily pill that combines three essential ingredients such as relugolix, estradiol and norethindrone acetate. It provides proven relief for premenopausal women with two indications in one pill. This provides an alternative treatment option for women who cannot or prefer not to use hormone therapy.
The endometriosis market covered in this report is segmented –
1) By Type: Superficial Peritoneal Lesion; Endometrioma; Deeply Infiltrating Endometriosis; Other Types
2) By Treatment Type: Hormonal Therapy; Pain Management
3) By Drug: Oral Contraceptives; Progestins; Nonsteroidal Anti-Inflammatory Drugs (NSAIDs); Gonadotropin Releasing Hormone (GnRH) Analogues; Levonorgestrel-Releasing Intrauterine Devices (LNR-IUDs); Other Drugs
4) By End-User: Hospitals; Homecare; Specialty Centers; Other End-Users
Get an inside scoop of the endometriosis market, Request now for Sample Report @
https://www.thebusinessresearchcompany.com/sample.aspx?id=13035&type=smp
Regional Insights –
North America was the largest region in the endometriosis market in 2023. The regions covered in endometriosis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Key Companies –
Major players in the endometriosis market are Pfizer Inc., F. Hoffmann-La Roche AG, Merck And Co. Inc., Abbvie Inc., Bayer AG, Bristol-Myers Squibb Company, GlaxoSmithKline PLC, AstraZeneca PLC, Abbott Laboratories, Eli Lilly and Company, Mylan N.V., Astellas Pharma Inc., Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Limited, Ipsen Pharma Biotech S.A.S., Cadila Pharmaceuticals Ltd., Gedeon Richter PLC, Torrent Pharmaceuticals Ltd., Neurocrine Biosciences Inc., Ferring Pharmaceuticals, Prestige Consumer Healthcare Inc., Almirall S.A, Evotec BioSystems GmbH, Serum Institute of India Pvt. Ltd., Kissei Pharmaceutical Co. Ltd., Sanofi India Ltd., DebioPharm Group, Repros Therapeutics Inc., Meditrina Pharmaceuticals Private Limited, Zenomed Healthcare Private Limited.
Table of Contents
1. Executive Summary
2. Endometriosis Market Report Structure
3. Endometriosis Market Trends And Strategies
4. Endometriosis Market – Macro Economic Scenario
5. Endometriosis Market Size And Growth
…..
27. Endometriosis Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix
Explore Related Our Reports
https://topprnews.com/iron-deficiency-injectable-market-overview/
https://topprnews.com/pituitary-dwarf-treatment-market-growth/
https://topprnews.com/global-tempered-glass-cutting-machine-market-share/
https://goodprnews.com/global-iron-deficiency-injectable-market-overview/
https://goodprnews.com/pituitary-dwarf-treatment-market-driver/
https://goodprnews.com/global-tempered-glass-cutting-machine-market-overview/
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
